Literature DB >> 20834221

Isolation, enrichment, and maintenance of medulloblastoma stem cells.

Xi Huang1, Tatiana Ketova, Ying Litingtung, Chin Chiang.   

Abstract

Brain tumors have been suggested to possess a small population of stem cells that are the root cause of tumorigenesis. Neurosphere assays have been generally adopted to study the nature of neural stem cells, including those derived from normal and tumorous tissues. However, appreciable amounts of differentiation and cell death are common in cultured neurospheres likely due to sub-optimal condition such as accessibility of all cells within sphere aggregates to culture medium. Medulloblastoma, the most common pediatric CNS tumor, is characterized by its rapid progression and tendency to spread along the entire brain-spinal axis with dismal clinical outcome. Medulloblastoma is a neuroepithelial tumor of the cerebellum, accounting for 20% and 40% of intracranial and posterior fossa tumor in childhood, respectively. It is now well established that Shh signaling stimulates proliferation of cerebellar granule neuron precursors (CGNPs) during cerebellar development. Numerous studies using mouse models, in which the Shh pathway is constitutively activated, have linked Shh signaling with medulloblastoma. A recent report has shown that a subset of medulloblastoma cells derived from Patched1(LacZ/+) mice are cancer stem cells, which are capable of initiating and propagating tumors. Here we describe an efficient method to isolate, enrich and maintain tumor stem cells derived from several mouse models of medulloblastoma, with constitutively activated Shh pathway due to a mutation in Smoothened (hereon referred as SmoM2), a GPCR that is critical for Shh pathway activation. In every isolated medulloblastoma tissue, we were able to establish numerous highly proliferative colonies. These cells robustly expressed several neural stem cell markers such as Nestin and Sox2, can undergo serial passages (greater than 20) and were clonogenic. While these cultured tumor stem cells were relatively small, often bipolar with high nuclear to cytoplasmic ratio when cultured under conditions favoring stem cell growth, they dramatically altered their morphology, extended multiple cellular processes, flattened and withdrew from the cell cycle upon switching to a cell culture medium supplemented with 10% fetal bovine serum. More importantly, these tumor stem cells differentiated into Tuj1+ or NeuN+ neurons, GFAP+ astrocytes and CNPase+ oligodendrocytes, thus highlighting their multi-potency. Furthermore, these cells were capable of propagating secondary medulloblastomas when orthotopically transplanted into host mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20834221      PMCID: PMC3229217          DOI: 10.3791/2086

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

1.  Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum.

Authors:  V A Wallace
Journal:  Curr Biol       Date:  1999-04-22       Impact factor: 10.834

2.  A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway.

Authors:  Junhao Mao; Keith L Ligon; Elena Y Rakhlin; Sarah P Thayer; Roderick T Bronson; David Rowitch; Andrew P McMahon
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

Review 3.  Medulloblastoma: from molecular pathology to therapy.

Authors:  Alessandra Rossi; Valentina Caracciolo; Giuseppe Russo; Krzysztof Reiss; Antonio Giordano
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

Review 4.  Combining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumors of the nervous and endocrine systems in children.

Authors:  M Sue O'Dorisio; Geetika Khanna; David Bushnell
Journal:  Cancer Metastasis Rev       Date:  2008-12       Impact factor: 9.264

5.  Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes.

Authors:  Joon Won Yoon; Richard Gilbertson; Stephen Iannaccone; Philip Iannaccone; David Walterhouse
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

Review 6.  Medulloblastoma stem cells.

Authors:  Xing Fan; Charles G Eberhart
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

7.  Sonic hedgehog regulates the growth and patterning of the cerebellum.

Authors:  N Dahmane; A Ruiz i Altaba
Journal:  Development       Date:  1999-06       Impact factor: 6.868

8.  Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog.

Authors:  R J Wechsler-Reya; M P Scott
Journal:  Neuron       Date:  1999-01       Impact factor: 17.173

9.  Dual and opposing roles of primary cilia in medulloblastoma development.

Authors:  Young-Goo Han; Hong Joo Kim; Andrzej A Dlugosz; David W Ellison; Richard J Gilbertson; Arturo Alvarez-Buylla
Journal:  Nat Med       Date:  2009-08-23       Impact factor: 53.440

10.  Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice.

Authors:  Ryan B Corcoran; Tal Bachar Raveh; Monique T Barakat; Eunice Y Lee; Matthew P Scott
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

View more
  14 in total

1.  Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.

Authors:  J Rodriguez-Blanco; L Pednekar; C Penas; B Li; V Martin; J Long; E Lee; W A Weiss; C Rodriguez; N Mehrdad; D M Nguyen; N G Ayad; P Rai; A J Capobianco; D J Robbins
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

2.  Selective enrichment of CD133+/SOX2+ glioblastoma stem cells via adherent culture.

Authors:  Ke Lv; Zhenyu Chen; Xiaoqing Zhang; Quanbin Zhang; Ling Liu
Journal:  Oncol Lett       Date:  2018-07-17       Impact factor: 2.967

3.  RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.

Authors:  Xuesong Zhao; Tatyana Ponomaryov; Kimberly J Ornell; Pengcheng Zhou; Sukriti K Dabral; Ekaterina Pak; Wei Li; Scott X Atwood; Ramon J Whitson; Anne Lynn S Chang; Jiang Li; Anthony E Oro; Jennifer A Chan; Joseph F Kelleher; Rosalind A Segal
Journal:  Cancer Res       Date:  2015-06-30       Impact factor: 12.701

Review 4.  Pharmacogenomics and cancer stem cells: a changing landscape?

Authors:  Francesco Crea; Maria Ana Duhagon; William L Farrar; Romano Danesi
Journal:  Trends Pharmacol Sci       Date:  2011-04-27       Impact factor: 14.819

5.  A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.

Authors:  Jezabel Rodriguez-Blanco; Bin Li; Jun Long; Chen Shen; Fan Yang; Darren Orton; Sara Collins; Noriyuki Kasahara; Nagi G Ayad; Heather J McCrea; Martine F Roussel; William A Weiss; Anthony J Capobianco; David J Robbins
Journal:  Clin Cancer Res       Date:  2018-11-28       Impact factor: 12.531

6.  T-cell TGF-β signaling abrogation restricts medulloblastoma progression.

Authors:  David Gate; Moise Danielpour; Javier Rodriguez; Gi-Bum Kim; Rachelle Levy; Serguei Bannykh; Joshua J Breunig; Susan M Kaech; Richard A Flavell; Terrence Town
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-31       Impact factor: 11.205

7.  An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma.

Authors:  Thomas K Albert; Marta Interlandi; Martin Sill; Monika Graf; Natalia Moreno; Kerstin Menck; Astrid Rohlmann; Viktoria Melcher; Sonja Korbanka; Gerd Meyer Zu Hörste; Tobias Lautwein; Michael C Frühwald; Christian F Krebs; Dörthe Holdhof; Melanie Schoof; Annalen Bleckmann; Markus Missler; Martin Dugas; Ulrich Schüller; Natalie Jäger; Stefan M Pfister; Kornelius Kerl
Journal:  Neuro Oncol       Date:  2021-04-12       Impact factor: 12.300

8.  The histone deacetylase inhibitor sodium butyrate promotes cell death and differentiation and reduces neurosphere formation in human medulloblastoma cells.

Authors:  Carolina Nör; Felipe A Sassi; Caroline Brunetto de Farias; Gilberto Schwartsmann; Ana Lucia Abujamra; Guido Lenz; Algemir Lunardi Brunetto; Rafael Roesler
Journal:  Mol Neurobiol       Date:  2013-03-21       Impact factor: 5.590

9.  Widespread contribution of Gdf7 lineage to cerebellar cell types and implications for hedgehog-driven medulloblastoma formation.

Authors:  Frances Y Cheng; Xi Huang; Anuraag Sarangi; Tatiana Ketova; Michael K Cooper; Ying Litingtung; Chin Chiang
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

10.  EAG2 potassium channel with evolutionarily conserved function as a brain tumor target.

Authors:  Xi Huang; Ye He; Adrian M Dubuc; Rintaro Hashizume; Wei Zhang; Jüri Reimand; Huanghe Yang; Tongfei A Wang; Samantha J Stehbens; Susan Younger; Suzanne Barshow; Sijun Zhu; Michael K Cooper; John Peacock; Vijay Ramaswamy; Livia Garzia; Xiaochong Wu; Marc Remke; Craig M Forester; Charles C Kim; William A Weiss; C David James; Marc A Shuman; Gary D Bader; Sabine Mueller; Michael D Taylor; Yuh Nung Jan; Lily Yeh Jan
Journal:  Nat Neurosci       Date:  2015-08-10       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.